DIANA DILLMAN: Open Payments
NPI 1235192188 · JENISON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,172 in 11 payments from 6 companies in 2025. Trend: 2023 $645 · 2024 $1,230 · 2025 $1,172
Food & beverage: $1,172
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $480 |
| Novo Nordisk Inc | 2 | $248 |
| AstraZeneca Pharmaceuticals LP | 2 | $138 |
| Gilead Sciences, Inc. | 1 | $123 |
| Lilly USA, LLC | 1 | $115 |
| ABBVIE INC. | 1 | $67 |
Products named: OTEZLA, Repatha, Ozempic, AIRSUPRA, Wegovy, Yeztugo, ZEPBOUND, FARXIGA.
Industry payments across MI — which companies pay providers there.
